PRME stock news

PRME stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.

See the full wire

20 wire items

2026-10-28 18:08:00 UTC#531159duplicateconfirmednews

Prime Medicine shares rise on first patient dosed in PM577a Wilson disease trial and FDA rare pediatric designation

dow_jonesimportance 0.30trust 0.80Prime Medicine, Inc. +0.70PM577a +0.70Wilson disease +0.70+1 entities

2026-10-28 17:53:00 UTC#531063newconfirmednews

Prime Medicine shares jump 21% as first patient dosed in PM577a Wilson disease trial; FDA grants rare pediatric designation

dow_jonesimportance 0.60trust 0.80Prime Medicine, Inc. +0.70PM577a +0.70Wilson disease +0.50+2 entities

2026-10-23 11:00:10 UTC#506113newforecastnews

Prime Medicine (PRME) Q3 2026 Earnings Preview: Analysts Expect $1.33M Revenue and ($0.24) EPS

tradingviewimportance 0.30trust 0.60Prime Medicine, Inc. 0

2026-10-16 00:03:13 UTC#469115duplicateconfirmedpress release

Prime Drink Group Corp. (PRME) announces CA$4.0M subscription receipt financing with CA$2.5M lead order

financial postimportance 0.30trust 0.80Prime Drink Group Corp. +0.10

2026-10-15 23:56:00 UTC#469096newconfirmednews

Prime Drink Group Corp. (PRME) launches CA$4.0M subscription receipt financing with CA$2.5M lead order

tradingviewimportance 0.40trust 0.60Prime Drink Group Corp. -0.20

2026-10-05 12:00:00 UTC#413271duplicateconfirmednews

Prime Medicine doses first patient in Phase 1/2 trial of PM577a for Wilson disease

tradingviewimportance 0.40trust 0.70Prime Medicine, Inc. +0.40PM577a +0.40Wilson disease +0.30+1 entities

2026-10-05 12:00:00 UTC#413218newconfirmedpress release

Prime Medicine doses first patient in Phase 1/2 trial of PM577a for H1069Q-mutated Wilson disease

globenewswireimportance 0.50trust 0.90Prime Medicine, Inc. +0.50PM577a +0.50Wilson disease +0.40+1 entities

2026-09-30 19:03:59 UTC#393859duplicateconfirmednews

Prime Drink Group files delayed financials, expects British Columbia CTO revocation

reutersimportance 0.30trust 0.80Prime Drink Group Corp. +0.40British Columbia Securities Commission +0.40

2026-09-30 14:56:27 UTC#392510newconfirmedpress release

Prime Drink Group Corp. (PRME) files delayed annual and interim financial statements, expects CTO revocation

financial postimportance 0.30trust 0.90Prime Drink Group Corp. +0.40

2026-09-25 12:19:00 UTC#368558newconfirmednews

Chardan Capital maintains $7.00 price target on Prime Medicine (PRME)

dow_jonesimportance 0.30trust 0.60Prime Medicine, Inc. 0Chardan Capital Markets, LLC 0

2026-09-24 22:05:59 UTC#365807duplicateconfirmedpress release

Prime Medicine receives FDA clearance for PM647 IND in AATD treatment, initial data expected in 2027

reutersimportance 0.30trust 0.90Prime Medicine, Inc. +0.60U.S. Food and Drug Administration +0.40PM647 +0.60+1 entities

2026-09-24 21:32:32 UTC#365743newconfirmedpress release

Prime Drink Group Corp. issues bi-weekly status report on management cease trade order

financial postimportance 0.30trust 0.90Prime Drink Group Corp. -0.30British Columbia Securities Commission -0.20

2026-09-24 21:23:00 UTC#365672duplicateconfirmednews

Prime Medicine shares rise 13% following FDA clearance of PM647 IND for AATD treatment

dow_jonesimportance 0.30trust 0.90Prime Medicine, Inc. +0.80Food and Drug Administration +0.80PM647 +0.80+1 entities

2026-09-24 21:08:00 UTC#365582newconfirmednews

Prime Medicine shares rise 13% after FDA clears IND application for PM647 to treat AATD

dow_jonesimportance 0.60trust 0.90Prime Medicine, Inc. +0.70U.S. Food and Drug Administration +0.50PM647 +0.70+2 entities

2026-09-21 11:38:02 UTC#341978newconfirmedpress release

Prime Drink Group Corp. (PRME) finalizes $1.01M debt settlement with Roynat and FAC

financial postimportance 0.40trust 0.90Prime Drink Group Corp. +0.50Roynat Inc. +0.20Financement Agricole Canada +0.20

2026-09-15 14:44:22 UTC#314725newconfirmednews

Prime Medicine (PRME) updates gene editing pipeline for Wilson disease, Alpha-1, and CGD; cash runway into 2027

quartrimportance 0.40trust 0.50Prime Medicine, Inc. +0.40

2026-09-10 21:31:09 UTC#295424updateconfirmedpress release

Prime Drink Group Corp. (PRME) issues bi-weekly status report on management cease trade order

financial postimportance 0.30trust 0.90Prime Drink Group Corp. -0.30British Columbia Securities Commission -0.20

2026-09-10 11:31:27 UTC#291481newconfirmedpress release

Prime Drink Group Corp. (PRME) closes $1.35M first tranche of non-brokered private placement

financial postimportance 0.30trust 0.90Prime Drink Group Corp. +0.10

2026-09-10 11:30:00 UTC#291532duplicateconfirmedpress release

Prime Drink Group Corp. closes $1.35M first tranche of non-brokered private placement

globenewswireimportance 0.30trust 1.00Prime Drink Group Corp. -0.10Canadian Securities Exchange 0

2026-08-27 21:31:56 UTC#231883updateconfirmedpress release

Prime Drink Group Corp. (PRME) issues bi-weekly status report on management cease trade order

financial postimportance 0.30trust 0.90Prime Drink Group Corp. -0.30British Columbia Securities Commission -0.20